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INTRODUCTION
Laryngeal cancer constitutes 26-30% of all head and neck ma-
lignant tumors (1). It is remarkably common in men and it is pri-
marily distributed between ages 40 and 70 years old, but the fre-
quency rate is the highest between ages 50 and 60. Well-known 
etiologic factors of laryngeal cancer include smoking, alcohol, 
human papilloma virus and radiation. It has been reported that 
the occurrence rate is up to 20 times higher in smokers compared 
to non-smokers, but the exact pathogenesis of the disease is still 
unknown. 
  The hypothesis that gastric acid reflux plays a role in the de-
velopment of squamous cell carcinoma of the larynx was first 
suggested by Gabriel and Jones (2) in 1960, and it has also been 
suggested that the chronic stimulation caused by acid reflux leads 
to a malignant change in the laryngopharyngeal mucosa (3). Sin-
ce the mid-80’s, a high frequency of acid reflux has been report-
ed in laryngeal cancer patients who do not drink alcohol or smoke 
cigarettes, and this had lead to an increased interest in the rela-
tionship between laryngeal cancer and acid reflux (4). Also, it is 
well known that gastroesophageal reflux (GER) plays a role in 
the development of cancer of the lower esophagus, suggesting 
that laryngopharyngeal reflux (LPR) may also play a role in the 
development of laryngeal cancer (5-7). However, there is still a 
great deal of controversy surrounding the significance and role 
of LPR.
  Therefore, we performed this study to confirm the significance 
of LPR as an etiologic factor of laryngeal cancer by measuring 
the frequency and severity of LPR by 24-hour ambulatory dou-
ble probe pH monitoring in patients with laryngeal cancer and 
the control group.
Objectives. To evaluate the significance of laryngopharyngeal reflux (LPR) as a risk factor in laryngeal cancer. 
Methods. We performed a case-control study with 29 consecutive laryngeal cancer patients who had undergone 24-hour 
ambulatory double pH monitoring from 2003 to 2006. The control group included 300 patients who had undergone 
24-hour ambulatory double pH monitoring due to LPR-related symptoms. We analyzed the prevalence of LPR and 
numerous parameters from the 24-hour ambulatory double pH monitoring in the laryngeal cancer patient and con-
trol groups. Pathologic LPR is defined when more than three episodes of LPR occur in 24 hours.
Results. The prevalence of pathologic LPR was significantly higher in the laryngeal cancer group than the control group 
(P=0.049). The reflux number of the upper probe was significantly higher in the laryngeal cancer group (P<0.001). 
However the effects of pathologic LPR on laryngeal cancer risk were diluted after adjusting for smoking and alcohol 
consumption in the multivariable logistic regression.
Conclusion. The pathologic LPR might be a possible risk factor in the development of laryngeal cancer. A further study 
should be necessary to verify the exact role of LPR in laryngeal cancer.
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MATERIALS AND METHODS
From April 2003 to August 2006, we studied 29 consecutive la-
ryngeal cancer patients who had undergone 24-hour ambulatory 
double probe pH monitoring. We included all laryngeal cancer 
patients except those who did not consent to pH monitoring. All 
of those in the laryngeal cancer group were newly diagnosed 
and did not receive any previous treatment. Informed consent 
was obtained from each patient, and the Institutional Review 
Board of Hanyang University Hospital approved the study pro-
tocol. 
  All laryngeal cancers were squamous cell carcinoma. The aver-
age age of the laryngeal cancer group was 62.0±9.45, and there 
were 27 (93.1%) males and 2 (6.9%) females. The subsites of 
laryngeal cancer were the glottis in 24 cases (82.8%), and the 
supraglottis in 5 cases (17.2%). 
  The control group included 300 patients who had undergone 
24-hour ambulatory double-probe pH monitoring due to LPR-
related symptoms such as chronic cough, globus sensation, hoar-
seness and throat clearing during the same period. The control 
group showed no specific findings of precancerous lesion such as 
leukoplakia or malignant tumors of the larynx or pharynx. The 
average age of the control group was 47.7±12.20, and there 
were 129 (43.0%) males and 171 (57.0%) females. 
  Twenty four-hour ambulatory double probe pH monitoring 
was performed to evaluate LPR. Under laryngopharyngeal en-
doscopy, we inserted a Zinetics 24 double-probe catheter trans-
nasally, and placed the upper probe just above the cricopharyn-
geus muscle, and the lower probe 15 cm below the upper probe. 
All findings were recorded for 24 hours using the Digitrapper
TM 
pH recorder (Medtronic Inc., Shoreview, MN, USA). Analysis 
was carried out using the Polygram 98 Diagnostic Workstation 
(ver. 2.2.0.2558).
  A LPR event was defined by an abrupt decrease in pH to be-
low 4 in the upper probe, with an accompanying or preceding 
decrease in pH to below 4 in the lower probe, except while eat-
ing food. Pathologic LPR is defined when more than three epi-
sodes of LPR occur (8). 
  We analyzed whether or not there were differences among 
the groups in the frequency of pathologic LPR and in parame-
ters measured during the 24-hour ambulatory double-probe pH 
monitoring, including total episodes of reflux, the percent time 
in which the pH fell below 4 in the supine, upright, and total 
position, and the DeMeester Score. The DeMeester score deter-
mined by calculating the measured value of the six components: 
1) total percent time pH less than 4.0, 2) percent time pH less 
than 4.0 in the upright position, 3) percent time pH less than 4.0 
in the supine position, 4) the total number of reflux episodes, 5) 
the total number of reflux episodes longer than 5 minutes, and 
6) the duration of the longest reflux episode (9). The score is au-
tomatically calculated and reported by the Polygram 98 Diag-
nostic Workstation (ver. 2.2.0.2558) software program. 
  The SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA) was used 
for statistical analysis, the Pearson’s chi-square test was used for 
the comparison of LPR frequency, and a one-way ANOVA me-
thod was used for the comparison of the measured parameters 
during 24-hour ambulatory double-probe pH monitoring. A mul-
tivariable logistic regression model was used to adjust age, gen-
der and the well-known risk factors of laryngeal cancer such as 
tobacco-smoking and alcohol consumption. P<0.05 was consid-
ered significant.
RESULTS
The laryngeal cancer group showed a significantly higher frequ-
ency of pathologic LPR (86.2%) compared to the control group 
(70.3%, P=0.049) (Table 1). 
  Among the 29 cases of laryngeal cancer, there were 15 (51.7%) 
cases in stage I, 9 (31.0%) cases in stage II, 2 (6.9%) cases in sta-
ge III, and 3 (10.4%) cases in stage IV. There was no statistical 
correlation between the frequency of pathologic LPR and the 
disease stage. 
  The average number of total episodes of LPR detected in the 
laryngeal cancer group was 10.86±8.57, which was significantly 
higher compared to 5.37±5.42 in the control group (P<0.001). 
From the upper probe, there were no significant differences no-
ticed between two groups for the percent times for the pH fall-
ing below 4 in the supine, upright, and total positions and the 
DeMeester Scores (Table 2). 
  To eliminate the effect of tobacco-smoking and alcohol con-
sumption in the evaluation of LPR and laryngeal cancer risk, we 
performed multivariable logistic regression test while adjusting 
for tobacco-smoking and alcohol consumption. The smoker was 
significantly higher in the laryngeal cancer group (26/29, 89.7%) 
than the control group (137/300, 45.6%; P<0.001). The alcohol 
Table 1. Prevalence of pathologic laryngopharyngeal reflux (LPR)
Control (n=300) Laryngeal cancer (n=29) P-value*
LPR  + (n=251) 211 (70.3) 25 (86.2) 0.049
          - (n=99)   89 (29.7)   4 (13.8)
Values are presented as number (%).
*Analysis using Pearson’s chi-square test. 
Table 2. Comparative results for parameters from the upper probe
Control 
(n=300)
Laryngeal cancer 
(n=29)
P-value*
Reflux number 5.37±5.42 10.86±8.57 <0.001
Pt pH <4 (total)
† 0.35±0.61   0.44±0.58 0.125
Pt pH <4 (upright)
† 0.50±1.00   0.79±1.43 0.310
Pt pH <4 (supine)
† 0.16±0.64   0.14±0.41 0.490
DeMeester score 2.35±2.96   2.86±3.12 0.553
*One-way ANOVA method; 
†Pt pH<4: percent time in which the pH fell 
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drinker was 17/29 (58.2%) in the laryngeal cancer group and 
142/300 (47.3%) in the control group. The alcohol drinker dose 
not differ between two groups (P=0.224). The adjusted odds ra-
tios and 95% confidence intervals of pathologic LPR, smoking 
and alcohol drinking were 2.77 (95% confidence interval [CI], 
0.57 to 13.40), 6.86 (95% CI, 1.79 to 26.29) and 1.12 (95% CI, 
0.71 to 1.85) respectively (Table 3). The analysis showed that 
only tobacco-smoking is significantly associated with laryngeal 
cancer risk (P=0.005). The effect of pathologic LPR on laryngeal 
cancer risk was diluted after the multivariable logistic regression. 
DISCUSSION
LPR is a disease where backflow of gastric contents over the 
esophageal sphincter produces laryngopharyngeal symptoms 
such as throat pain, coughing, hoarseness, and globus sensation. 
It is observed in 10-30% of all patients that visit an otolaryngol-
ogy clinic, and more than half of the patients have a voice prob-
lem or laryngeal disorder that is, in some way, related to LPR. 
LPR causes numerous chronic laryngeal disorders such as con-
tact granuloma and ulcers, chronic laryngitis, subglottic stenosis, 
vocal polyps, laryngeal spasms, dysphonia and in the worst case 
scenario, laryngeal cancer (8, 10, 11).
  The mostly highly supported theory for the causal role bet-
ween LPR and laryngeal cancer is that chronic and repetitive 
chemical stimulation of gastric acid reflux leads to damage and 
changes of the laryngeal mucosa (12). This theory is especially 
supported by research showing that the laryngeal mucosa is mu-
ch more susceptible to gastric acid than the esophageal mucosa 
(13). Laryngeal cancer typically develops in the anterior portion 
of the vocal cords and rarely in the posterior portion of the lar-
ynx, where carbonic anhydrase is expressed and neutralizes acid, 
thereby protecting the posterior portion of the larynx from gas-
tric acid (14). As a result, the anterior portion of the larynx is 
relatively susceptible to laryngeal cancer because it is not pro-
tected from gastric acid. This is indirect evidence that gastric acid 
causes laryngeal cancer. It is also known that bile, which is in-
cluded in gastric contents, overexpresses COX-2, which can cau-
se esophageal cancer. It has been suggested that this might also 
contribute to the development of laryngeal cancer (12). This the-
ory is also supported by an article reporting that achlorhydric 
patients who have undergone a total gastrectomy have a higher 
incidence of laryngeal cancer than patients with simple indiges-
tion (15).
  There are studies in progress to address whether or not gastric 
acid reflux is related to laryngeal cancer, but the exact role of 
gastric acid reflux in the development of laryngeal cancer is still 
unknown. One study suggested a correlation between GER and 
laryngeal cancer based on a study of 5 cases (16), and there has 
been a case report of a non-smoker with a granuloma that de-
veloped into laryngeal cancer, which supports the possibility that 
LPR has a role in the development of laryngeal cancer (17). To 
evaluate the relationship between LPR and GER with laryngeal 
cancer, the prevalence rates in laryngeal cancer patients and in a 
control group need to be compared. However, the difference in 
prevalence rates between LPR and GER in laryngeal cancer are 
significant in certain studies but not in others. Some studies re-
ported that GER occurred in 25-67% of laryngeal cancer pa-
tients and the incidence was higher in the laryngeal cancer group 
compared with the control group (5). Copper et al. (18) report-
ed a 62% occurrence rate of LPR and 67% occurrence rate of 
pathologic GER in laryngeal and pharyngeal cancer patients. 
Ozl  ugedik et al. (19) reported a 62% occurrence rate of LPR 
and a 45% occurrence rate of pathologic GER in laryngeal can-
cer patients, although there was no significant difference when 
compared to the control group. In this study, the incidence of 
pathologic LPR was 86.2% in the laryngeal cancer group, which 
was much higher than that in the control group (70.3%; P=
0.049). Also, the total number of reflux episodes recorded in the 
upper probe in the laryngeal cancer group was 10.86, which 
was two times higher than that of the control group (P<0.001). 
In this study, the frequency of LPR in the patient group and con-
trol group were relatively higher compared to that in previous 
studies in which the sensitivity of machinery and difference in 
criteria were taken into account.
  The criteria for pathologic LPR has not yet been established, 
although Ozlugedick et al. (19) defined pathologic LPR as hav-
ing only one episode of reflux in the upper probe and Copper 
et al. (18) defined pathologic LPR as when the percentage of 
time that the pH fell below 4 was more than 0.1% of the total 
time, and/or more than 0.2% of the time in the upright position, 
and/or more than 0% of the time in the supine position. In this 
study, we used strict criteria to define pathologic LPR as more 
than 3 episodes of reflux in 24 hours as previous our study so 
that we could evaluate its exact role in the development of la-
ryngeal cancer (8). 
  We were able to confirm that the frequencies and degrees of 
pathologic LPR are much more severe in the laryngeal cancer 
group than in the control groups. Based on these results, it could 
be suggested that pathologic LPR might play a role in the devel-
opment of laryngeal cancer. However the effects of pathologic 
LPR on laryngeal cancer risk were diluted after adjusting for 
smoking and alcohol consumption in the multivariable logistic 
regression. The analysis showed that only tobacco-smoking is 
Table 3. Effects of pathologic laryngopharyngeal reflux (LPR), smok-
ing and alcohol on laryngeal cancer risk 
Factors
Adjusted odds ratio 
(95% confidence interval)
P-value 
LPR 2.77 (0.57-13.40) 0.204
Smoking* 6.86 (1.79-26.29) 0.005
Alcohol drinking
† 1.12 (0.71-1.85) 0.367
*Smokers: 1; never smokers: 0; 
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significantly associated with laryngeal cancer risk and the effect 
of pathologic LPR was diluted. Therefore, it is not clear that pa-
thologic LPR is a real causative factor or cofounder in the devel-
opment of laryngeal cancer. In order to overcome the limitation 
of this study, further study with the larger sample size should be 
necessary while comparing with the true normal control group 
who has no LPR-related symptoms. 
  In order to evaluate the exact role of LPR in the development 
of laryngeal cancer, normal individuals with absolutely no sign 
of laryngeal symptoms could be selected for the control group. 
However, executing a 24-hour ambulatory double probe pH mo-
nitoring in normal individuals with no laryngeal symptoms is 
actually very difficult. In a study carried out by Bacciu et al. (6) 
based on laryngeal cancer patients with no history of smoking 
or drinking and a normal control group consisting of individuals 
with no abnormal laryngeal findings, GER was noticed in 27.7% 
in the laryngeal cancer group and 4.8% in the control group. In 
our study, the control group consisted of patients with LPR-re-
lated symptoms, rather than normal individuals. However, the 
frequencies of LPR among patients complaining of actual LPR 
symptoms were higher than those in the normal control group 
(19). Therefore, we believe that if the occurrence of LPR is ex-
ceptionally higher in the laryngeal cancer group than in a con-
trol group with LPR-related symptoms the results would be sig-
nificantly higher when comparing laryngeal cancer patients with 
a control group of normal individuals. 
  In conclusion, the prevalence and severity of LPR was signifi-
cantly higher in laryngeal cancer patients than in the control 
group with LPR-related symptoms. Therefore, our results sup-
port that pathologic LPR might be a possible risk factor in the 
development of laryngeal cancer although the effect of patho-
logic LPR on laryngeal cancer risk was diluted after adjusting 
for smoking and alcohol consumption. A further study with larg-
er sample size should be necessary to verify the exact role of 
LPR as a risk factor in laryngeal cancer. 
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